Skip to main content
Terug
Watch Compare

BIO KEY INTERNATIONAL INC

Datakwaliteit: 83%
BKYI
Nasdaq Technology Software
€ 0,56
▼ € 0,01 (-1,85%)
Marktkapitalisatie: 6,09 M
Prijs
€ 0,56
Marktkapitalisatie
6,09 M
Dagbereik
€ 0,55 — € 0,57
52-Weeksbereik
€ 0,49 — € 1,97
Volume
55.740
Openen € 0,57
50D / 200D Gem.
€ 0,62
10,21% below
50D / 200D Gem.
€ 0,73
22,68% below

Quick Summary

Belangrijkste Punten

Negative free cash flow of -3,35 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-65,96%
Onder sectorgemiddelde (1,78%)
ROIC-43,42%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio1,26
Interest Coverage-27,42

Waardering

PE (TTM)
-1,43
Onder sectorgemiddelde (-0,15)
P/B Ratio1,01
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Technology sector mediaan (1058 peers)
Metriek Aandeel Sector Mediaan
P/E -1,4 -0,2
P/B 1,0 3,0
ROE % -66,0 1,8
Net Margin % — -0,5
Rev Growth 5Y % — 7,3
D/E — 0,4

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -4,25 M
ROE -65,96% ROA -41,23%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -3,35 M
ROIC -43,42% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,26
Interest Coverage -27,42 Asset Turnover N/A
Working Capital 781.785 Tangible Book Value 5,16 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,43 Forward P/E N/A
P/B Ratio 1,01 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -55,04%
Market Cap 6,09 M Enterprise Value 4,05 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -0,31 OCF / Share -0,31
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 78,76%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue — — — — —
Net Income -4,30 M -8,52 M -11,91 M -5,07 M -9,67 M
EPS (Diluted) — — — — —
Gross Profit 5,64 M 1,43 M 4,58 M 3,44 M 2,04 M
Operating Income -4,01 M -8,83 M -9,92 M -4,94 M -4,47 M
EBITDA — — — — —
R&D Expenses 2,51 M 2,39 M 3,25 M 2,36 M 1,40 M
SG&A Expenses 7,14 M 7,86 M 9,36 M 6,03 M 5,85 M
D&A 93.026,0 75.136,0 — — —
Interest Expense 175.755,0 218.270,0 10.462,0 18.000,0 4,34 M
Income Tax -22.998,0 -134.014,0 20.434,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 8,62 M 4,52 M 11,34 M 17,77 M 22,52 M
Total Liabilities 4,84 M 3,45 M 6,04 M 2,15 M 2,19 M
Shareholders' Equity 3,77 M 1,06 M 5,30 M 15,62 M 20,34 M
Total Debt 44.762,0 188.787,0 2,92 M 0,0 232.000,0
Cash & Equivalents 437.604,0 511.400,0 2,64 M 7,75 M 16,99 M
Current Assets 1,89 M 2,62 M 8,98 M 14,01 M 18,94 M
Current Liabilities 4,55 M 3,21 M 5,46 M 2,00 M 1,88 M